OptimizeRx Corporation
OPRX
$17.00
-$0.25-1.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 169.67% | -2,719.23% | 99.15% | -127.59% | 41.89% |
| Total Depreciation and Amortization | -0.20% | -35.87% | 55.93% | 0.00% | 0.70% |
| Total Amortization of Deferred Charges | 92.45% | 381.82% | -79.93% | 8.30% | 0.00% |
| Total Other Non-Cash Items | -4.49% | -64.61% | -48.01% | 191.76% | -8.05% |
| Change in Net Operating Assets | -99.07% | 156.34% | -590.61% | 84.99% | -86.27% |
| Cash from Operations | 18.04% | 1,851.52% | -88.94% | 129.03% | -63.08% |
| Capital Expenditure | 62.96% | -58.82% | 5.56% | 60.00% | -40.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.35% | 44.66% | -39.19% | -85.00% | 66.94% |
| Cash from Investing | 47.62% | 30.00% | -30.43% | -8.24% | 44.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -800.00% | 80.00% | -400.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 94.25% | 73.15% | -912.50% | 92.29% | -196.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -667.46% | 79.21% | -430.83% | 41.86% | -42.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.62% | 216.28% | -335.30% | 635.32% | -116.45% |